Pass the MRCP (SCE) Neurology Revision Guide

Cover
Half Title
Series
Title
Copyright
Contents
Preface
Author
Contributors
Chapter 1 Cerebrovascular Diseases
Chapter 2 Epilepsy and Sleep Disorders
Chapter 3 Disorders of Cranial Nerves and Visual System
Chapter 4 Disorders of Peripheral Nerves, Motor Neuron and Muscle—Part 1: Disorders of Peripheral Nerve and Motor Neuron
	Abbreviations
	1. PERIPHERAL NEUROPATHY
		Table 4.1 Differential Diagnosis of Neuropathy Based on Involvement (Continued)
		Anti-MAG Antibody Neuropathy
		CANOMAD
		Wartenberg Migratory Sensory Neuritis
		CMT (Charcot–Marie–Tooth Disease)
			Classification of CMT
			Figure 4.1 Genetic abnormalities in different types of CMT/ HSMN.
			HNPP
			How to Say Whether There Is a Possibility of an Inherited Neuropathy or an AcquiredDisease?
		MMN-CB
	2. MOTOR SYSTEM DISORDERS
		MND
			Table 4.4 Difference between MND and MMN-CB
			BOX 4.3 IMPORTANT POINTS ABOUT MND FOR EXAM
		SBMA (Kennedy Disease)
		SMA (Spinal Muscular Atrophy)
			Table 4.5 Types of SMA
	3. AUTONOMIC SYSTEM NEUROPATHIES
		AAG (Autoimmune Autonomic Ganglionopathy)
		PAF (Pure Autonomic Failure)
		POTS (Postural Orthostatic Tachycardia + Joint Hypermobility Syndrome)
		Transthyretin Neuropathy
	4. OTHER COMMON CLINICAL NEUROPATHIES
		Diabetes Neuropathies: Types
			BOX 4.5 PATHOGENESIS OF DIABETES NEUROPATHIES
			BOX 4.6 DM AUTONOMIC NEUROPATHY
			BOX 4.7 DM AMYOTROPHY/PLEXOPATHY
		Inflammatory Radiculoneuropathies (AIDP/CIDP)
			BOX 4.8 SIDS-GBS
			BOX 4.9 PROBABILITY OF MOBILITY IN GBS
			Figure 4.2 Variants of GBS/AIDP described in literature.
			Concept of Nodo-Paranodopathies
			BOX 4.10 EXAMPLE OF A CASE SCENARIO OFNODO-PARANODOPATHY WOULD BE
			Infectious Poly-Radiculitis
Chapter 5 Disorders of Peripheral Nerves, Motor Neuron and Muscle—Part 2: Muscle Diseases
Chapter 6 Disorders of the Spinal Cord
Chapter 7 Neuro-Genetics
Chapter 8 Neuro-Endocrinology and Neuro-Toxicology
Chapter 9 Neuro-Inflammatory Diseases
Chapter 10 Neuroradiology and Neuropathology
Chapter 11 Cognitive Disorders and Dementia
	Abbreviations
	1. CLINICAL TESTS
	2. LOCALIZATIONS OF COMMON CLINICAL SIGNS AND SYMPTOMS
		Left parietal lobe
		3. Non-dominant (Right
		4. Left anterior temporal
		5. Anterior thalamic
		6. Left thalamus
		7. Right Anterior nucleus
		8. Bilateral medial frontal
		9. Caudate infarct
	3. PPA: PRIMARY PROGRESSIVE APHASIA
		Figure 11.1 MRI brain
		2. LvPPA
		3. Agrammatic PNFA
		4. PP-AOS
		Figure 11.3 Differentiating between different types of aphasia.
	4. CCAS: CEREBELLAR COGNITIVE AFFECTIVE SYNDROME
	5. ELDERLY DEGENERATIVE DEMENTIAS
		1. LBD/DLBD
		2. AD
			Figure 11.4 MRI coronal and PET imaging in
		3. PCA
			Figure 11.5 Sagittal and coronal MRI in a
		4. NPH
		5. CAA
	6. NPH: FEATURES OF DESH
	FTD
		bvFTD clinical features mnemonic: (A-B-C-D-E-F) and its localization
	7. EARLY-ONSET AD (<65 YEARS)
	8. AD PATHOLOGY ESSENTIAL POINTS
	9. AUTOIMMUNE DEMENTIAS
	10. CHRONIC TRAUMATIC ENCEPHALOPATHY (CTE)
	11. HIPPOCAMPAL SCLEROSIS MAY BE SEEN IN
	12. TREATMENT OF DEMENTIAS
		Figure 11.6 Drugs used in treatment of dementia.
		Figure 11.7 MRI findings in Alzheimer’s disease (AD). Tl-weighted images demonstrate prominenthippocampal and medial temporal lobe atrophy, moderate diffuse cortical atrophy and ventricularenlargement in an 81 year old with AD dementia, subsequently confirmed at autopsy. D(FLAIR)sequence demonstrates sub-cortical and periventricular white matter hyperintensities in a 78 yearold with a clinical diagnosis of AD, likely representing comorbid small vessel ischemic disease.E, Hallmarks of CAA, including scattered microbleeds and superficial siderosis, are revealed on(SWI) in a 75 year old with acute altered mental status superimposed on progressive memory andexecutive dysfunction. F, Confluent WM hyperintensities on FLAIR in a 75 year old with pathologyprovensevere cerebral amyloid angiopathy and AD neuropathology.
Chapter 12 Neurosurgery
	1. IMPORTANT EXAM POINTS FOR NEUROSURGERY AND CRITICAL CARE
	Prognosis of ambulation after SCI depends on
	2. COMPLICATIONS IN NEURO-CRITICAL CARE
Chapter 13 Pain and Headache
	Abbreviations
	1. HEADACHE
		2.Cortical SAH
		3. RCVS
			Figure 13.1 RCVS2 score for differentiating RCVS from other arteriopathies.
		4. Ciliary ganglio-
		5. SMART
		6. Pituitary apoplexy
		11. Menstrual
		12. Red ear syndrome
		13. MOH
	2. PRIMARY HEADACHE DISORDERS
		Figure 13.4 Distinguishing features between various primary headache disorders.
	3. SECONDARY AND OTHER HEADACHE DISORDERS
		1. Epicrania fugax
		2. Glossopharyngeal
		3. GCA/temporal
		4. Fibromyalgia
		5. Primary exercise
		6. SIH
		7. CRPS 1,2
			Figure 13.2 Diagnostic criteria for CRPS.
			Figure 13.3 IgG4 disease: MRI brain showing pachymeningeal enhancement and biopsy showingstoriform pattern.
			Diagnostic criteria cut-offs
			Figure 13.4 Distinguishing features between various primary headache disorders.
	4. IMPORTANT CLINICAL POINTS FOR DIAGNOSIS OF MIGRAINE AND OTHERHEADACHES
		Figure 13.4 Distinguishing features between various primary headache disorders.
		phases of migraine headache:
		Figure 13.5 Phases of a migraine headache attack.
		Migraine with AURA
		Important points about migraine medications
		Important points about migraine medications
		e. Migraine and women
		f. Childhood migraine
	5. NICE GUIDELINES: HEADACHE
		MIGRAINE
		5. CH (CLUSTER HEADACHE)
	6. TTH: NO OPIOIDS FOR TTH (TENSION-TYPE HEADACHE)
	7. MOH (MEDICATION OVERUSE HEADACHE)
Chapter 14 Movement Disorders
	Abbreviations
	1. CONGENITAL MDS: CHOREA SYNDROMES (CAUDATE ATROPHY)
		Figure 14.1 Peripheral blood film showing acanthocytes.
		2. HD
		3. Wilson
	2. CHOREA GRAVIDARUM
		BOX 14.1 CAUSES OF CHOREA GRAVIDARUM
	3. CONGENITAL MDS: NBIA (GLOBUS PALLIDUS AND THALAMUSINVOLVEMENT)
	4. IDIOPATHIC (LATE-ONSET) MOVEMENT DISORDERS WHICH MAY OR MAYNOT AFFECT COGNITION
Chapter 15 Neuro-Infections
	Abbreviations
	1. CREUTZFELDT–JAKOB DISEASE (CJD)
		Figure 15.1 Axial DWI MRI images showing cortical ribboning.
		Figure 15.2 Axial MRI FLAIR images showing pulvinar sign.
	2. BACTERIAL MENINGITIS AND ENCEPHALITIS
		MENINGITIS:
		3. Neisseria
		4. Listeria
		5. WD
	3. VIRAL INFECTIONS OF THE NERVOUS SYSTEM
		1. HSV
		2. NMDA
		3. KBS
		4. VZV
		5. SSPE
		6. Hepatitis-C
		7. HAD
		8. PML
		9. HIV-Myelopathy
		Figure 15.7 Estimating the risk of PML in a patient of HIV.
		BOX 15.1 RISK OF PML IN A PATIENT OF HIV ON NATALIZUMAB
		10. EEE
		11. WNV
		12. MVE
	4. PARASITIC INFECTIONS
		1. Toxoplasma
		2. NCC
	5. NEUROMUSCULAR DISEASES AND MISCELLANEOUS
		1. GBS:
		2. GBS due to Zika
		3. Lyme disease
		4. Botulism
		5. LD
Index
	A
	B
	C